Accuray | ARAY - Betriebsergebnis





Betriebsergebnis Veränderung Datum
Abbott USD 2.25B 73M 2025-12
Accuray USD 4.71M 6.86M 2024-12
AngioDynamics USD -9.97M 1.12M 2025-02
Artivion USD 4.79M 6.85M 2025-12
AtriCure USD 2.49M 2.28M 2025-12
Boston Scientific USD 1.24B 203M 2025-12
Edwards Lifesciences USD 370.3M 54.8M 2025-12
Hologic USD 237M 16M 2025-12
Inogen USD -7.79M 728K 2024-09
Mesa Laboratories USD 5.78M 2.27M 2024-12
Orthofix International USD 6.12M 1.91M 2025-12
Surmodics USD -5.64M 276K 2024-09
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Trinity Biotech USD -509K 6.27M 2025-09